Clinical Trial Update: Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic Steatohepatitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating metadoxine for non-alcoholic steatohepatitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• Metadoxine (metadoxine)

Snippet

Sponsor: Hospital General de Mexico | Conditions: Non-alcoholic Steatohepatitis | Phase 3 | Status: WITHDRAWN